75 related articles for article (PubMed ID: 30144436)
1. Increased kielin/chordin-like protein levels are associated with the severity of heart failure.
Ye J; Wang Z; Wang M; Xu Y; Zeng T; Ye D; Liu J; Jiang H; Lin Y; Wan J
Clin Chim Acta; 2018 Nov; 486():381-386. PubMed ID: 30144436
[TBL] [Abstract][Full Text] [Related]
2. The cysteine-rich domain protein KCP is a suppressor of transforming growth factor beta/activin signaling in renal epithelia.
Lin J; Patel SR; Wang M; Dressler GR
Mol Cell Biol; 2006 Jun; 26(12):4577-85. PubMed ID: 16738323
[TBL] [Abstract][Full Text] [Related]
3. The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and metabolic syndrome in mice.
Soofi A; Wolf KI; Emont MP; Qi N; Martinez-Santibanez G; Grimley E; Ostwani W; Dressler GR
J Biol Chem; 2017 Jun; 292(22):9051-9062. PubMed ID: 28424263
[TBL] [Abstract][Full Text] [Related]
4. Kielin/chordin-like protein deficiency causes cardiac aging in male mice.
Ye D; Feng Y; Pan H; Lu X; Wang Z; Wang M; Liu J; Xu Y; Zhang J; Zhao M; Xu S; Ye J; Wan J
J Mol Med (Berl); 2023 Jun; 101(6):731-742. PubMed ID: 37149518
[TBL] [Abstract][Full Text] [Related]
5. The kielin/chordin-like protein KCP attenuates nonalcoholic fatty liver disease in mice.
Soofi A; Wolf KI; Ranghini EJ; Amin MA; Dressler GR
Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G587-G598. PubMed ID: 27514479
[TBL] [Abstract][Full Text] [Related]
6. Kielin/chordin-like protein enhances induction of osteoblast differentiation by Bone Morphogenetic Protein-2.
Nagasaki K; Yamada A; Sasa K; Kamijo R
FEBS Open Bio; 2023 Jul; 13(7):1357-1364. PubMed ID: 37226930
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of thrombospondin-1 in failing hearts may favor ventricular remodeling.
Batlle M; Pérez-Villa F; Lázaro A; García-Pras E; Vallejos I; Sionis A; Castel MA; Roig E
Transplant Proc; 2009; 41(6):2231-3. PubMed ID: 19715883
[TBL] [Abstract][Full Text] [Related]
8. Kielin/chordin-like protein deficiency aggravates pressure overload-induced cardiac dysfunction and remodeling via P53/P21/CCNB1 signaling in mice.
Xu Y; Zheng Z; Pan H; Zhao M; Zhang J; Peng S; Liu J; Pan W; Yin Z; Xu S; Wei C; Qin JJ; Lin Y; Wan J; Wang M
FASEB J; 2024 Mar; 38(5):e23513. PubMed ID: 38421300
[TBL] [Abstract][Full Text] [Related]
9. Kielin/chordin-like protein attenuates both acute and chronic renal injury.
Soofi A; Zhang P; Dressler GR
J Am Soc Nephrol; 2013 May; 24(6):897-905. PubMed ID: 23539757
[TBL] [Abstract][Full Text] [Related]
10. Altered Expression of Bone Morphogenetic Protein Accessory Proteins in Murine and Human Pulmonary Fibrosis.
Murphy N; Gaynor KU; Rowan SC; Walsh SM; Fabre A; Boylan J; Keane MP; McLoughlin P
Am J Pathol; 2016 Mar; 186(3):600-15. PubMed ID: 26765958
[TBL] [Abstract][Full Text] [Related]
11. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
12. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.
Engebretsen KV; Lunde IG; Strand ME; Waehre A; Sjaastad I; Marstein HS; Skrbic B; Dahl CP; Askevold ET; Christensen G; Bjørnstad JL; Tønnessen T
FEBS J; 2013 May; 280(10):2382-98. PubMed ID: 23480731
[TBL] [Abstract][Full Text] [Related]
13. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease.
Lin J; Patel SR; Cheng X; Cho EA; Levitan I; Ullenbruch M; Phan SH; Park JM; Dressler GR
Nat Med; 2005 Apr; 11(4):387-93. PubMed ID: 15793581
[TBL] [Abstract][Full Text] [Related]
14. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.
Saito Y; Nakao K; Arai H; Nishimura K; Okumura K; Obata K; Takemura G; Fujiwara H; Sugawara A; Yamada T
J Clin Invest; 1989 Jan; 83(1):298-305. PubMed ID: 2521342
[TBL] [Abstract][Full Text] [Related]
15. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.
Li X; Zhang ZL; Wang HF
Biomed Pharmacother; 2017 Sep; 93():130-145. PubMed ID: 28624424
[TBL] [Abstract][Full Text] [Related]
16. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
[TBL] [Abstract][Full Text] [Related]
17. Enhanced bioactive myocardial transforming growth factor-β in advanced human heart failure.
Khan S; Joyce J; Margulies KB; Tsuda T
Circ J; 2014; 78(11):2711-8. PubMed ID: 25298166
[TBL] [Abstract][Full Text] [Related]
18. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic receptors and calcium cycling proteins in non-failing, hypertrophied and failing human hearts: transition from hypertrophy to failure.
DiPaola NR; Sweet WE; Stull LB; Francis GS; Schomisch Moravec C
J Mol Cell Cardiol; 2001 Jun; 33(6):1283-95. PubMed ID: 11444930
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
